or Try an Advanced Search...

    Treatment Of Diabetes Stocks List

    Symbol Grade Name % Change
    ASND D Ascendis Pharma A/S -0.75
    IONS D Ionis Pharmaceuticals, Inc. -0.57
    ORMP F Oramed Pharmaceuticals Inc. 6.96
    PODD F Insulet Corporation 1.23
    BDX F Becton, Dickinson and Company 0.46
    BMY F Bristol-Myers Squibb Company 0.34
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Diabetes Insulin Medicine S&P 500 Biotechnology Cancer Dystrophy Endocrine System Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Hepatitis C Virus Infection Hypertension Lipodystrophy Peptide Hormones Pharmaceutical Acromegaly Alcohol Alport Syndrome

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Diabetes stocks.

    Symbol Grade Name Weight
    MEDI D Harbor Health Care ETF 16.22
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.86
    IHI C iShares U.S. Medical Devices ETF 6.25
    GDOC C Goldman Sachs Future Health Care Equity ETF 5.82
    MEDX F Horizon Kinetics Medical ETF 5.43
    View all Treatment Of Diabetes ETFs...
    Compare ETFs
    Compare FTXH to GDOC Compare GDOC to MEDX Compare MEDI to MEDX

        Treatment Of Diabetes Stocks Recent News

        Date Stock Title
        Apr 26 BMY Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
        Apr 26 BMY Q1 2024 Bristol-Myers Squibb Co Earnings Call
        Apr 26 BMY Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
        Apr 25 ASND Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
        Apr 25 BMY Bristol Myers Squibb stock tumbles on cost-cutting initiative
        Apr 25 BMY Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off
        Apr 25 BMY Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
        Apr 25 BMY Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
        Apr 25 BMY Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
        Apr 25 BMY Bristol-Myer Squibb Company (BMY) Q1 2024 Earnings Call Transcript
        Apr 25 BMY Update: Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall
        Apr 25 BMY Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
        Apr 25 BMY Why Bristol Myers Squibb Stock Is Sinking Today
        Apr 25 BMY Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
        Apr 25 BMY Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
        Apr 25 BMY Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
        Apr 25 BMY Bristol Myers Cuts Full-Year Earnings Forecast, Launches Cost Cuts
        Apr 25 BMY Is Bristol Myers Squibb Stock a Millionaire Maker?
        Apr 25 BMY AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
        Apr 25 BMY Bristol-Myers to cut 2,200 jobs as part of $1.5B cost savings plan
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Diabetes Insulin Medicine S&P 500 Biotechnology Cancer Dystrophy Endocrine System Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Hepatitis C Virus Infection Hypertension Lipodystrophy Peptide Hormones Pharmaceutical Acromegaly Alcohol Alport Syndrome
        Treatment Of Diabetes

        Treatment of diabetes focuses on keeping blood sugar levels within a normal range. This can be achieved through lifestyle changes, such as eating a healthy diet, exercising regularly, and maintaining a healthy weight. Medications may also be necessary to help control blood sugar levels. In some cases, insulin injections may be required.

        Browse All Tags